KILITCH

The stock has been placed in Enhanced Surveillance Measure (ESM) list ESM - I (34).

Kilitch Drugs (India) Ltd.

NSE: KILITCH

BSE: 524500

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

172.40+0.0 (+0.01%)

26 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

68.0 / 100

Value Score

48.4 / 100

Price Momentum Score

56.4 / 100

QVM Score

63.5 / 100

Key Metrics

Market Cap

602.74

P/E (TTM)

20.71

P/B

2.16

P/S (TTM)

2.54

EV/EBITDA

17.17

CAPE (5Y)

31.38

ROE (TTM)

12.52

ROCE (TTM)

10.72

ROA (TTM)

7.83

Avg 3Y ROE

11.84

Earnings 3Y CAGR

33.35

Sales 3Y CAGR

18.46

Sales 5Y CAGR

24.93

Debt/Equity

0.32

Consensus TP

232.00

Strong Buy %

Promoter Holding

63.77

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Kilitch Drugs (India) Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 20.71 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -32.21%

What is P/E Ratio?

Median: 30.55

Value 20.71

-0.99726.77

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 14.04% for 12-month ended 30 Jun 2026 and the growth was 3.45 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 14.04

-99.6111701.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.32 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.08 in the last 1 year

What is Debt to Equity?

Negative

Moderate ROE but declining trend

The company reported moderate ROE of 12.52% for 12-month ended 30 Jun 2026 but ROE declined by -158 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of 0.95% for 12-month ended 30 Jun 2026 and the growth was 6.25 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate and stable operating margin

The company reported moderate operating margin of 13.66% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -75 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 35.9 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

35.9 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Kilitch Drugs (India) Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Kilitch Drugs (India) Ltd. Shareholding Pattern

Quarterly breakdown of Kilitch Drugs (India) Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	68.90	68.70	68.70	68.63	68.63	68.33	68.33	68.25	68.25	68.25	68.25	68.25	68.25	68.25	69.23	69.23	69.23	69.23	69.23	69.23	69.23	69.23	63.77	63.77	63.77	63.77
Indian Promoter	68.90	68.70	68.70	68.63	68.63	68.33	68.33	68.25	68.25	68.25	68.25	68.25	68.25	68.25	69.23	69.23	69.23	69.23	69.23	69.23	69.23	69.23	63.77	63.77	63.77	63.77
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	31.10	31.30	31.30	31.37	31.37	31.67	31.67	31.73	31.75	31.75	31.75	31.75	31.75	31.75	30.77	30.77	30.77	30.77	30.76	30.77	30.77	30.76	36.23	36.23	36.22	36.11
Bodies Corporate	0.74	0.67	0.43	0.47	0.55	0.58	0.57	0.74	0.64	0.51	0.59	0.74	0.72	0.75	0.96	0.88	1.71	1.95	2.06	1.38	1.72	1.78	1.45	1.20	1.07	0.73
Others (incl. Retail) No. of shareholders	30.36 9,780	30.63 10,693	30.87 10,569	30.90 9,947	30.82 9,704	31.09 9,160	31.10 8,690	30.99 9,073	31.11 9,080	31.24 9,160	31.16 9,331	31.01 9,388	31.03 9,475	31.00 9,523	29.81 8,951	29.89 9,009	29.06 9,473	28.82 9,566	28.70 9,857	29.39 10,072	29.05 9,690	28.98 10,323	34.78 10,867	35.03 11,982	35.15 11,719	35.38 12,550

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Kilitch Drugs (India) Ltd. is not part of any tracked index.

Prominent Investor Holdings

Sharad Kanayalal Shah and Associates

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Kilitch Drugs (India) Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Bhavin Mukund Mehta Promoter & Director	August-2024	Inter-se Transfer (Disposal) 28th Aug 2024	20.92 %	₹ 0.00	8.41 lac	₹ 0.00
Mira Bhavin Mehta Director	August-2024	Inter-se Transfer (Acquisition) 28th Aug 2024	0.00 %	₹ 0.00	8.41 lac	₹ 0.00
Bhavin Mukund Mehta Director	April-2022	Inter-se Transfer (Acquisition) 25th Apr 2022	12.85 %	₹ 0.00	11.12 lac	₹ 0.00
Mukund Mehta Promoter & Director	April-2022	Inter-se Transfer (Disposal) 25th Apr 2022	12.85 %	₹ 0.00	11.12 lac	₹ 0.00

Corporate Actions

History of Kilitch Drugs (India) Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 1 existing shares
Ex-date: 24th Mar 2026Announced on: 11th Feb 2026
Rights Issue(2 new shares @ ₹357 for 23 existing shares)
Ex-date: 15th Jul 2025Announced on: 2nd Jul 2025
"Rights ISIN INE729D20010 CINS Y4775M109 SEDOL BNZHSJ1."
Dividend₹ 0.50/share
Record date: 23rd Sep 2019Ex-date: 20th Sep 2019
Announced on: 30th May 2019
Dividend₹ 0.50/share
Record date: 19th Sep 2018Ex-date: 18th Sep 2018
Announced on: 25th May 2018
Dividend₹ 30/share
Record date: 25th Sep 2012Ex-date: 24th Sep 2012
Announced on: 30th Aug 2012

Company Profile

Overview of Kilitch Drugs (India) Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers prod...

Key personnel

Mr. Sunil Sureshji Jain

Chief Financial Officer

Ms. Pushpa Nyoupane

Chief Compliance Officer, Company Secretary

Mrs. Mira Bhavin Mehta

Managing Director

Mr. Mukund Prataprai MehtaD

Managing Director, Executive Director

Mr. Bhavin Mukund MehtaD

Wholetime Director

Mr. Dipen Jayantilal JainD

Additional Non-Executive Independent Director

Prof. Murti Vasudev KrishnaD

Non-Executive Independent Director

Mr. Venkita Subramanian RajanD

Non-Executive Independent Director

View all

Incorporated on

12 May 1992

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

236

IPO date

14 Feb 1994

Free Float

98,74,322

Website

https://www.kilitch.com/

Phone no.

+912261214100

Address

UJAGAR INDUSTRIAL ESTATE UNIT NO. 37, W T PATIL MARG, DEONAR, , 400088, India

Frequently Asked Questions

What is the current share price of Kilitch Drugs (India) Ltd.?

The current share price of Kilitch Drugs (India) Ltd. is ₹ 172.40 as of 26 Aug 2026.

What is the market capitalisation of Kilitch Drugs (India) Ltd.?

The market capitalisation of Kilitch Drugs (India) Ltd. stands at ₹ 602.74 Cr.

What is the PE ratio of Kilitch Drugs (India) Ltd.?

The Price-to-Earnings (PE) ratio of Kilitch Drugs (India) Ltd. is 20.71 as of the latest trailing twelve months data.

What is the ROE and ROCE of Kilitch Drugs (India) Ltd.?

Kilitch Drugs (India) Ltd. has a Return on Equity (ROE) of 12.52% and a Return on Capital Employed (ROCE) of 10.72% as per the latest financial reports.

What is the 52-week high and low of Kilitch Drugs (India) Ltd.?

The 52-week high of Kilitch Drugs (India) Ltd. is - and the 52-week low is -.

What is the dividend yield of Kilitch Drugs (India) Ltd.?

The dividend yield of Kilitch Drugs (India) Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Kilitch Drugs (India) Ltd.?

Foreign Institutional Investors (FII) hold 0.12%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 35.38% of Kilitch Drugs (India) Ltd. shares.

What sector does Kilitch Drugs (India) Ltd. belong to?

Kilitch Drugs (India) Ltd. operates in the Healthcare sector.

What is the beta of Kilitch Drugs (India) Ltd.?

The beta of Kilitch Drugs (India) Ltd. is 1.12, indicating its price volatility relative to the broader market. Over the past 1 year, Kilitch Drugs (India) Ltd. has delivered an absolute return of -17.13%.

What is the RSI of Kilitch Drugs (India) Ltd.?

The 14-day Relative Strength Index (RSI) of Kilitch Drugs (India) Ltd. is 44.67, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Kilitch Drugs (India) Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Kilitch Drugs (India) Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Holdings and Presence

Stock Analysis

Corporate Actions

Company Profile